Cargando…

Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study

PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ríos, A., Rodríguez, M. A., Puñal, J. A., Moreno, P., Mercader, E., Ferrero, E., Ruiz-Pardo, J., Morlán, M. A., Martín, J., Durán-Poveda, M., Bravo, J. M., Casanova, D., Egea, M. P. Salvador, Torregrosa, N. M., Exposito-Rodríguez, A., Martínez-Fernández, G., Carrión, A. M., Vidal, O., Herrera, F., Ruiz-Merino, G., Rodríguez, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722874/
https://www.ncbi.nlm.nih.gov/pubmed/36251077
http://dx.doi.org/10.1007/s00423-022-02704-4
_version_ 1784844052346175488
author Ríos, A.
Rodríguez, M. A.
Puñal, J. A.
Moreno, P.
Mercader, E.
Ferrero, E.
Ruiz-Pardo, J.
Morlán, M. A.
Martín, J.
Durán-Poveda, M.
Bravo, J. M.
Casanova, D.
Egea, M. P. Salvador
Torregrosa, N. M.
Exposito-Rodríguez, A.
Martínez-Fernández, G.
Carrión, A. M.
Vidal, O.
Herrera, F.
Ruiz-Merino, G.
Rodríguez, J. M.
author_facet Ríos, A.
Rodríguez, M. A.
Puñal, J. A.
Moreno, P.
Mercader, E.
Ferrero, E.
Ruiz-Pardo, J.
Morlán, M. A.
Martín, J.
Durán-Poveda, M.
Bravo, J. M.
Casanova, D.
Egea, M. P. Salvador
Torregrosa, N. M.
Exposito-Rodríguez, A.
Martínez-Fernández, G.
Carrión, A. M.
Vidal, O.
Herrera, F.
Ruiz-Merino, G.
Rodríguez, J. M.
author_sort Ríos, A.
collection PubMed
description PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence in Spain. METHODS: Spanish multicenter longitudinal analytical observational study was conducted. Patients with FPTMC received treatment with curative intent and presented cure criteria 6 months after treatment. Recurrence rate and disease-free survival (DFS) were analyzed. Two groups were analyzed: group A (no tumor recurrence) vs. group B (tumor recurrence). RESULTS: Ninety-four patients were analyzed. During a mean follow-up of 73.3 ± 59.3 months, 13 recurrences of FPTMC (13.83%) were detected and mean DFS was 207.9 ± 11.5 months. There were multifocality in 56%, bilateral thyroid involvement in 30%, and vascular invasion in 7.5%; that is to say, they are tumors with histological factors of poor prognosis in a high percentage of cases. The main risk factors for recurrence obtained in the multivariate analysis were the tumor size (OR: 2.574, 95% CI 1.210–5.473; p = 0.014) and the assessment of the risk of recurrence of the American Thyroid Association (ATA), both intermediate risk versus low risk (OR: 125, 95% CI 10.638–1000; p < 0.001) and high risk versus low risk (OR: 45.454, 95% CI 5.405–333.333; p < 0.001). CONCLUSION: FPTMC has a recurrence rate higher than sporadic cases. Poor prognosis is mainly associated with the tumor size and the risk of recurrence of the ATA. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9722874
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97228742022-12-07 Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study Ríos, A. Rodríguez, M. A. Puñal, J. A. Moreno, P. Mercader, E. Ferrero, E. Ruiz-Pardo, J. Morlán, M. A. Martín, J. Durán-Poveda, M. Bravo, J. M. Casanova, D. Egea, M. P. Salvador Torregrosa, N. M. Exposito-Rodríguez, A. Martínez-Fernández, G. Carrión, A. M. Vidal, O. Herrera, F. Ruiz-Merino, G. Rodríguez, J. M. Langenbecks Arch Surg Original Article PURPOSE: Familial papillary thyroid microcarcinoma (FPTMC) can present a more aggressive behavior than the sporadic microcarcinoma. However, few studies have analyzed this situation. The objective is to analyze the recurrence rate of FPTMC and the prognostic factors which determine that recurrence in Spain. METHODS: Spanish multicenter longitudinal analytical observational study was conducted. Patients with FPTMC received treatment with curative intent and presented cure criteria 6 months after treatment. Recurrence rate and disease-free survival (DFS) were analyzed. Two groups were analyzed: group A (no tumor recurrence) vs. group B (tumor recurrence). RESULTS: Ninety-four patients were analyzed. During a mean follow-up of 73.3 ± 59.3 months, 13 recurrences of FPTMC (13.83%) were detected and mean DFS was 207.9 ± 11.5 months. There were multifocality in 56%, bilateral thyroid involvement in 30%, and vascular invasion in 7.5%; that is to say, they are tumors with histological factors of poor prognosis in a high percentage of cases. The main risk factors for recurrence obtained in the multivariate analysis were the tumor size (OR: 2.574, 95% CI 1.210–5.473; p = 0.014) and the assessment of the risk of recurrence of the American Thyroid Association (ATA), both intermediate risk versus low risk (OR: 125, 95% CI 10.638–1000; p < 0.001) and high risk versus low risk (OR: 45.454, 95% CI 5.405–333.333; p < 0.001). CONCLUSION: FPTMC has a recurrence rate higher than sporadic cases. Poor prognosis is mainly associated with the tumor size and the risk of recurrence of the ATA. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-10-17 2022 /pmc/articles/PMC9722874/ /pubmed/36251077 http://dx.doi.org/10.1007/s00423-022-02704-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ríos, A.
Rodríguez, M. A.
Puñal, J. A.
Moreno, P.
Mercader, E.
Ferrero, E.
Ruiz-Pardo, J.
Morlán, M. A.
Martín, J.
Durán-Poveda, M.
Bravo, J. M.
Casanova, D.
Egea, M. P. Salvador
Torregrosa, N. M.
Exposito-Rodríguez, A.
Martínez-Fernández, G.
Carrión, A. M.
Vidal, O.
Herrera, F.
Ruiz-Merino, G.
Rodríguez, J. M.
Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title_full Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title_fullStr Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title_full_unstemmed Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title_short Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study
title_sort biological behavior of familial papillary thyroid microcarcinoma: spanish multicenter study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722874/
https://www.ncbi.nlm.nih.gov/pubmed/36251077
http://dx.doi.org/10.1007/s00423-022-02704-4
work_keys_str_mv AT riosa biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT rodriguezma biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT punalja biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT morenop biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT mercadere biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT ferreroe biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT ruizpardoj biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT morlanma biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT martinj biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT duranpovedam biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT bravojm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT casanovad biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT egeampsalvador biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT torregrosanm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT expositorodrigueza biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT martinezfernandezg biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT carrionam biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT vidalo biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT herreraf biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT ruizmerinog biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy
AT rodriguezjm biologicalbehavioroffamilialpapillarythyroidmicrocarcinomaspanishmulticenterstudy